Fused pyrimidinone systems have been important in drug design over many years due to diverse biological properties including antimicrobial, antiviral, antioxidant and antitumor activities [1] [2] [3] [4] . In particular, C3-arylated pyrido[1,2-a]pyrimidin-4-ones have been exploited in the design of pharmaceutically active compounds such as phosphoinositide 3-kinase (pi3k) inhibitors, endothelial cell dysfunction inhibitors, and CXCR3 antagonists [5] [6] [7] . The conventional methods previously reported for the synthesis (Gould-Jacob type reaction) [8] [9] [10] and the functionalization (Suzuki-Miyaura reaction) [11] of fused pyrimidinones have limitations in that they are multi-step reactions and require harsh reaction conditions. Recently, Guchhait showed a novel method for the synthesis of 3-aryl-pyrido[1,2-a]pyrimidin-4-ones by Pd-catalyzed Ag(I)-promoted activation-arylation of pyrido[1,2-a]pyrimidin-4-one [12] . We have also reported convenient synthesis of novel 3-phenylpyrimido[1,2-c] thienopyrimidinones as potent inhibitors of interlukin-6/ signal transducer and activator of transcription 3 (IL-6/ STAT3) by the one-pot reaction of formamidine derivatives of 4-aminothienopyrimidine with phenylacetyl chlorides [13] . Since STAT3 is frequently over-expressed or persistently activated in most tumors [14] , effective IL-6/STAT3 inhibitors could be useful candidates for development of new anticancer and anti-inflammatory drugs [15] .
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In [18] were easily prepared in quantitative yield by treatment of fused heterocyclic amines 1a-b, 5 and 8 with dimethylformamide dimethyl acetal (DMF-DMA), and they were used without isolation for the next reaction. The cyclization of 2a-b with various 2-phenylacetyl chlorides 3 in dichloromethane in the presence of a catalytic amount of triethylamine at room temperature gave 4a-f within 3 h in good to excellent yields. The reaction of 6 or 9 with 3 under similar conditions was also successfully carried out to afford corresponding 7a-e or 10a-e in good yields. The crude solid products obtained were easily isolated by filtration, washing and drying, and then purified by crystallization from ethanol. All products were fully characterized by spectral data and elemental analysis. The preliminary biological tests of IL-6/STAT3 inhibition for some synthesized compounds (4b, 7c, 10d) exhibited IC 50 values ranging from 1.5 μm to 5.8 μm [19] , and further pharmacological studies are still in progress.
Experimental
Melting points were measured using capillary tubes on a Büchi apparatus and are uncorrected. The reactions were monitored by thin-layer chromatography on Merck kieselgel 60F 254 plates and the products were purified by column chromatography using Merck silica gel (70-230 mesh). The 1 H NMR spectra were recorded on a Unity Inova 400NB FT NMR spectrometer at 400 MHz in DMSO-d 6 . Mass spectra were recorded on a HP 59580 B spectrometer with electrospray ionization in a positive ion mode. Elemental analyses were performed on a Carlo Erba 1106 elemental analyzer.
General procedure for the preparation of compounds 4a-f, 7a-e and 10a-e A mixture of heterocyclic amine 1a,b, 5 or 8 (5 mmol) and DMF-DMA (6 mmol) was heated under reflux for 3 h and then stirred at room temperature for 10 h and concentrated. The residue was treated with a solution of the appropriate acyl chloride 3 (5 mmol) in dichloromethane (10 mL) containing a catalytic amount of triethylamine. The resulting solution was stirred at room temperature for 3 h and the precipitated crude product was filtered, washed with ethyl acetate, and crystallized from ethanol. 3-(2-Chlorophenyl)-4H-pyrimido[1,2-c]quinazolin-4 
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